sertraline

Targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC – ESTRO

European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:

“Pre-clinical findings presented at ESTRO24 reveal that targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC (non-small cell lung cancer). This approach radiosensitises the tumor and reduces immune suppression.”

What is Non-Small Cell Lung Cancer? | Charles River

Read further.
Source: ESTRO/LinkedIn

cancer ESTRO European SocieTy for Radiotherapy and Oncology immune suppression non small cell lung cancer NSCLC OncoDaily Oncology radiosensitises serine/glycine metabolism sertraline